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Introduction 77
Crohn's disease (CD) remains an incompletely understood, inflammatory condition of 78 the intestine. Although there are important genetic components to its origins, there are also 79 undoubted environmental elements, amongst which dietary factors are clearly identifiable. 80
As well as having a probable role in pathogenesis, nutrition has been identified as a key 81 mediator in established disease, such that, in paediatrics at least, defined enteral nutrition 82 (EN) is the treatment of first choice for many patients. However, as is often the case in 83 clinical nutrition, the evidence base is not as strong as might be wished. Several meta-84 analyses have been conducted, but it remains difficult to judge the true effectiveness of EN in 85 patients with CD. The collected evidence supports a superior effect of corticosteroids over 86 EN in adults with CD, but many adult clinicians and most paediatricians believe that EN is an 87 appropriate and evidence-based primary therapy in CD. This belief rests on the positive 88 results from studies of paediatric and malnourished CD patients, which confirm beneficial 89 effects of EN in improving growth and nutritional status, but which also indicate mucosal 90 healing, and of course a favourable risk profile compared to pharmacological options. 91
Enteral nutrition comprises, however, a broad range of options, and the limited 92 comparative evidence prevents confidence that the best choice(s) can currently be made. 
Quality of studies 206
The quality of the included studies was highly variable. The study with the highest 207 quality [11] scored 26 (out of 28) by the assessment tool [9, 10] , while the lowest quality 208 study scored only 10 [12]. Poor (or unknown) representativeness of study subjects and the 209 lack of power calculations were the commonest defects overall, and in the controlled trials, 210
there were high risks of performance and detection bias due to the lack of blinding, and high 211 risk of selection bias due to the lack of allocation concealment during randomization 212 (Appendix B). 213
Characteristics of identified enteral feeds 214
No fewer than 29 distinct enteral feeds have been used in the published studies. We 215 have excluded one study [13] , and therefore data on two formulae, because patients who were 216 randomized to receive polymeric feeding were prescribed one or other of the two formulae 217 depending on availability, but the RR was provided only as a combined rate for the two 218 formulae. Therefore, the final number of reviewed formulae is 27: 4 elemental formulae and 219 23 non-elemental preparations. The fatty acid composition of these formulae with reference 220 to RR is demonstrated in Table 1 . More detailed fat composition data are provided in 221 Appendix B. 222
Correlation between fat composition and remission rate 223
Total amount of fat 224 M A N U S C R I P T
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Eight studies have compared a pair of feeds with different nutrient composition (e.g. 225 polymeric versus elemental or semi-elemental versus elemental). It is difficult to determine 226 the effect of fat content from these comparisons, as their composition for other nutrients was 227 not standardised. Only two studies have specifically examined the effect of the amount of 228 total fat. High and low fat feeds (fat mainly in the form of LCT) were compared. The earlier 229 study showed that the feed with a low percentage of fats (15.6% of total calories) achieved a 230 higher RR (92%), than the high fat feed (35.6% of total calories), which achieved a RR of 231 55% [7] . The later study indicated that a very low fat feed (1.15% of total calories) achieved 232 a significantly higher RR (80%) than a modest fat feed (11.27% of total calories), which 233 achieved a RR of (25%) [14] . It will be noted that the amount of fat in this higher fat feed 234 was barely distinguishable from that of the low fat feed of the earlier study and yet the 235 clinical effects were hugely different. Overall we find no significant correlation or trend 236 between total fat content and RR (r= 0.176, p= 0.252) ( Fig. 2A) . 237
Medium chain triglycerides (MCT) 238
Varying MCT content does not have a consistent strong effect. A single study which 239 compared a feed with added MCT against a feed with no MCT, generated significantly 240 different RRs of 77% and 67% respectively [15] . However, the high MCT feed was semi-241 elemental and the low MCT feed was elemental, which precludes any firm conclusions about 242 the contribution of the lipid to the observed differences. Our quantitative analysis, which is 243 based on results from all studies, finds a weak non-significant positive trend between MCT 244 delivery as a percentage of the total energy provision and RR (r = 0.072; p = 0.643) where the 245 range was from 0 to 30% of total energy supply (Fig. 2B) . The apparent outlier to the upper 246 left of the plot comes from Leiper's study [16] in which there was a particularly high 247 concentration of MCT (>86% of all fat) with a high proportion of MUFA (29%) and a low n-248 6:n-3 ratio (see below) amongst the fats that were LCTs. 249 M A N U S C R I P T
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Long chain triglycerides 250
The effect of undifferentiated LCTs has been addressed by comparing feeds with 251 similar amounts of total fat but with different percentages of LCT. One study (already 252 mentioned above) compared four feeds: elemental, elemental with added LCT, elemental 253 with added MCT, and semi-elemental [7] . The feed with high LCT was associated with the 254 lowest RR (55%), while the elemental feed with added MCT performed best, with a RR of 255 92%. However, a second study found no significant difference in RRs between use of feed 256 with 5% LCT and an isocaloric feed with 30% LCT [16] . Our quantitative analysis of all the 257 reported studies of all feedings reveals a non-significant negative trend between LCT 258 provision and RR (r = -0.254; p = 0.096) where the range was from 4 to 35% of total energy 259 supply and where in most cases the predominant lipids were of the n-6 class (where not, the 260 relative excess came from n-9 lipid which we also consider disadvantageous ( Fig. 2C and see  261 below). 262
Saturated fats 263
No single study has directly compared feeds with different levels of saturated fatty 264 acids. We found no significant correlation or trend between the amount of saturated fat and 265 the RRs (r = -0.007, p = 0.964) where the range was from trace amounts to over 30% of total 266 energy supply (Fig. 2D) . 267
Olive oil/MUFA 268
Only a single study has compared two feeds with the same amount of total fat but 269 with different amounts of oleic acid (balanced by linoleic acid) [11] . The feed with higher 270 oleic acid content (79% of total fat) was significantly less effective (RR = 27%) than the feed 271 with lower oleic acid (28%) and higher linoleic acid (45%), which achieved a RR of 63%. 272
Although there are no other specific studies addressing MUFAs, our overall quantitative 273 analysis is concordant, showing disadvantage from monounsaturated fatty acids (MUFA)M A N U S C R I P T
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with no statistical significance (r = -0.23, p = 0.13) with a range from trace amounts to about 275 25% of total energy supply (Fig. 2E) . 276
n-6 and n-3 PUFAs 277
Only the study by Gassull et al. has directly investigated the effect of an n-6-rich feed 278 (specifically linoleic acid), in which a significantly higher RR was achieved than with a lower 279 n-6 content [11] . No study of non-elemental formulae readily allows assessment of the 280 individual effects of an n-3-rich approach. 281
In our quantitative analysis a very weak non-significant negative correlation was 282 found between the amount and proportion of PUFA (of all types) and the response rates from 283 all feeds (r = -0.157, p = 0.308) (Fig. 2F) as was also the case for n-3 fatty acids (r = -0.166, p 284 = 0.313) (Fig. 2H) . 285
However, there was a weak positive correlation between the total n-6 fatty acid 286 content and response rates (r = 0.253, NS) ( Fig. 2G ), statistical significance (r= 0.378, p = 287 0.018) which remained significant after correction for multiple tests (Fig.2I ). In the subgroup 288 analysis (TABLE 2), when RR was stratified by the level of n-6:n-3, significant difference (p 289 = 0.011) was reported in the pooled RR between EEN feeds with moderate n-6:n-3 (58.94% 290 RR) (95% CI 48.99, 68.9) versus feeds with high n-6:n-3 (79.91% RR) (95% CI 72.31, 291
87.51). 292
When patients exposed to only a single oil are considered (informal subgroup 293 analysis) then the use of safflower oil is favoured, with a mean (median) response rate of 294 83.6% (84%) compared to the overall average response of 68.1% and mean (median) values 295 for isolated exposure to soybean or arachis oil of 63.7% (68.5%) and 68.6% (75%) 296
The wide range of patient characteristics, the low number of participants in each 299 study, and varying study designs obstruct the route to confident and generalizable 300 conclusions. We deliberately used results taken from observations on patients who followed 301 treatment protocols (rather than intention to treat), but although biologically justifiable this 302 will be of limited clinical value if a future "optimal" formula is not tolerated and thus the 303 treatment plan is not completed. Fortunately the compliance/acceptance of the many 304 different formulae did not appear systematically different according to the particular lipid 305
profiles. This may have been obscured however by the range of duration of the intended 306 therapies. The duration of intervention in most of the trials examined was between 3 and 8 307 weeks, 12 weeks in one trial [17] , and only 2 weeks in 3 studies [18] [19] [20] . 308
No fewer than eight different sets of criteria have been utilised to define response. 309
Some were strict and binary (e.g. complete steroid withdrawal) and associated with relatively 310 low response rates [21, 22] , while others were more qualitative (subjective). It should not 311 have had a major effect on our interpretations since a full analysis performed on this basis 312 provides the same qualitative results (data not shown). 313
Our methods may not have been sufficient to overcome bias introduced by the 314 differing anatomical location of the CD (small bowel, large bowel, or both). The trials with 315 the highest proportions of patients with small bowel CD (50% and 52%) also had amongst 316 the highest RRs (86% and 75% respectively)[21, 23], a linkage already well recognized in the 317 literature, and perhaps a confounder despite apparently well-matched controls. 318
It has been thought that EN is more effective in those with early, purely inflammatory 319 disease. Although not all evaluated studies provided the duration of the disease, the shortest 320 and longest mean disease durations (1.3 and 18 years) were associated with similar and veryM A N U S C R I P T could not be detected within our analysis [26] . 326
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The divergence between the different types of unsaturated LCTs (n-3, n-6 and n-9) 327
and outcome appear at first surprising, but are fully consistent with the negative results from 328 supplementary fish oil in CD [27] . In terms of specific oil content, interpretation is clouded 329 by the number of feeds which contain multiple oils. However the numerical advantage to 330 safflower oil is very much in line with the overall conclusion that high n-6:n-3 ratio is 331 advantageous and low proportion of MUFA could be relatively effective as well, given the 332 relative paucity of MUFA in safflower oil (13.9% compared to 23.9% in soy and 56% in 333 arachis oil) and its n-6:n-3 ratio, which, at over 90, is the highest of all the dietary oils. It has 334 been more difficult still to link interpretation to individual fatty acids, but linoleic acid is 335 favoured, and oleic acid as the only n-9 fatty acid in artificial feeds is targeted for avoidance. 336
There is a little supportive evidence also for our hypothesised complementary 337 combination of safflower oil and MCT. One of the highest response rates in the literature 338 (92% [7] ) was in patients on this combination, and only the study of Lindor et al appears to 339 point in the opposite direction, this being a small study in which the comparator was steroid 340 therapy [28] . 341
Conclusions 342
The fat content of EN formulae and its influence on controlling the inflammation of 343 CD has generated interest, but its true role has remained unclear. Given its potential 344 importance it is surprising that most authors have not thought it worthwhile or necessary to 345 disclose the lipid analysis of the formulae used in their study. This systematic review has M A N U S C R I P T M A N U S C R I P T 
A C C E P T E D ACCEPTED MANUSCRIPT
27
A C C E P T E D ACCEPTED MANUSCRIPT
